Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.8M Buy
63,010
+129
+0.2% +$44.2K 0.5% 34
2026
Q1
$22.1M Sell
62,881
-1,476
-2% -$526K 0.61% 29
2025
Q4
$21.1M Buy
64,357
+7,150
+12% +$2.27M 0.53% 32
2025
Q3
$16.1M Buy
57,207
+4,546
+9% +$1.32M 0.42% 33
2025
Q2
$14.7M Buy
52,661
+2,513
+5% +$712K 0.44% 35
2025
Q1
$15.3M Sell
50,148
-8,974
-15% -$2.65M 0.5% 28
2024
Q4
$15.4M Buy
+59,122
New +$17.5M 0.46% 31

Other funds holding AMGN

Avanza Fonder's AMGN Position: Q2 2026 in Review

Avanza Fonder increased its Amgen (AMGN) stake by 0.21% in Q2 2026, buying an estimated $44.2K and bringing the position to 63,010 shares worth $22.8M. The position accounts for 0.5% of the portfolio, ranked #34.

Avanza Fonder first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Avanza Fonder held 63,010 shares of Amgen worth $22.8M as of Q2 2026.
  • Avanza Fonder bought 129 Amgen shares in Q2 2026, an estimated $44.2K.
  • Amgen made up 0.5% of Avanza Fonder's portfolio in Q2 2026, its #34 holding.
  • Avanza Fonder first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.